Following COVID-19 vaccination, most patients with MS do not face an increased risk for relapse requiring corticosteroid therapy.

A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia.

Frailty is an independent risk factor for increased rates of readmission and inpatient mortality among hospitalized patients with SLE.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Ketamine treatment among patients with fibromyalgia may offer short-term pain relief, though its long-term efficacy and safety remain uncertain.

Parathyroidectomy vs nonoperative management was not associated with a reduced risk for depression among patients with hyperparathyroidism.

Policy interventions to mitigate heat-related illness are needed based on the relationship between high HVI and severe stroke.

For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes.